Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) CEO Christopher Gibson recently engaged in transactions involving the companys shares, according to a new SEC filing. Gibson sold a total of 65,000 shares of Class A Common Stock at a price range of $10.10 per share, resulting in a total sale value of $656,500.